GlassScriptPhysician profile
Yoel Brito
NPI 1437448271
$47,224.89
in general payments reported to CMS, 2019-2025
35 companies · $12K in 2025
The $12K reported for 2025 was more than what 93% of Pulmonary Disease providers received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $908 · 2020: $1,385 · 2021: $1,738 · 2022: $2,418 · 2023: $10K · 2024: $19K · 2025: $12K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $28K · Food and Beverage: $9,839 · Travel and Lodging: $3,298 · Education: $96.37.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $27,542.00 |
| Food and Beverage | $9,839.13 |
| Travel and Lodging | $3,298.03 |
| Education | $96.37 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $33,377.07 | 2019-2025 | Airsupra, Tezspire, Fasenra |
| Glaxosmithkline, LLC. | $3,626.89 | 2019-2025 | Nucala, Trelegy Ellipta, Arexvy |
| Chiesi USA, INC. | $2,315.59 | 2023 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $1,380.08 | 2019-2025 | Ofev, Stiolto Respimat, Spiriva Respimat |
| Genzyme Corporation | $884.91 | 2022-2025 | |
| Baxter Healthcare | $772.47 | 2022-2025 | Hillrom - Vest System Model 105 Home Care, Hillrom - Life 2000 Ventilation System |
| Mylan Specialty L.P. | $754.87 | 2019-2024 | Yupelri |
| Amgen INC. | $558.88 | 2022-2025 | Tezspire |
| Verona Pharma, INC. | $508.58 | 2025 | Ohtuvayre |
| Insmed, INC. | $484.81 | 2019-2025 | Arikayce, Brinsupri |
| Inogen, INC. | $419.05 | 2023-2024 | Inogen One G5 Oxygen Concentrator - Bluetooth |
| Philips North America LLC | $397.22 | 2022-2025 | (Ak6) Vest Therapy, (9369) Reusable Vest, Vest Therapy Und |
| Advanced Respiratory, INC | $354.85 | 2019-2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $268.20 | 2020-2025 | Glassia |
| Inspire Medical Systems, INC. | $227.90 | 2024 | Inspire |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Healthcare Solutions, INC. | $113.95 | 2022 | |
| Viatris Specialty LLC | $93.05 | 2025 | Yupelri |
| Sanofi-Aventis U.S. LLC | $78.99 | 2025 | |
| Sunovion Pharmaceuticals INC. | $77.82 | 2021 | |
| Grifols USA, LLC | $74.11 | 2019-2025 | Prolastin-C Liquid |
| Lilly USA, LLC | $56.58 | 2025 | Zepbound, Mounjaro |
| Merck Sharp & Dohme LLC | $52.06 | 2023-2024 | Keytruda |
| Circassia INC. | $48.34 | 2019 | |
| United Therapeutics Corporation | $47.13 | 2022-2025 | Tyvaso |
| Azurity Pharmaceuticals, INC. | $39.06 | 2025 | Alvesco |
| Pulmonx Corporation | $33.87 | 2023 | Zephyr Endobronchial Valve, Chartis Catheter, Zephyr Delivery Catheter |
| Fisher & Paykel Healthcare INC | $33.00 | 2024 | Fisher & Paykel Healthcare |
| Novartis Pharmaceuticals Corporation | $30.17 | 2023 | |
| Pfizer INC. | $25.63 | 2025 | |
| Ucb, INC. | $20.79 | 2019 | |
| Electromed, INC. | $19.26 | 2025 | Smartvest |
| Resmed Corp | $18.97 | 2022 | |
| Hikma Pharmaceuticals USA | $17.86 | 2024 | Ryaltris |
| Actelion Pharmaceuticals US, INC. | $12.88 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Yoel Brito listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.